CXBS (Corix Bioscience) Other Financing: $-1.59 Mil (TTM As of Sep. 2017)


What is Corix Bioscience Other Financing?

Corix Bioscience CXBS -99.00% Other Financing is $-1.59 Mil as of Sep. 2017.

Corix Bioscience's Other Financing for the three months ended in Sep. 2017 was $-1.41 Mil.

Corix Bioscience's Other Financing for the trailing twelve months (TTM) ended in Sep. 2017 was $-1.59 Mil.

Corix Bioscience Other Financing Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Other Financing Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Other Financing
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.57

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.13 -0.05 -1.41

Corix Bioscience Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-1.59 Mil mean?
Corix Bioscience (CXBS) has a Other Financing of $-1.59 Mil as of Sep. 2017. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Corix Bioscience and its competitors.
Is Corix Bioscience's Other Financing too high?
Corix Bioscience's current Other Financing is $-1.59 Mil.
How does Corix Bioscience's Other Financing compare to BKIT and YBAO?
Corix Bioscience's Other Financing of $-1.59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Corix Bioscience and its competitors. Corix Bioscience's current Other Financing is $-1.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Other Financing of $-1.59 Mil. The current Other Financing is $-1.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Other Financing is $-1.59 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.